• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇洗脱支架与裸金属支架相比可减少静脉桥血管的新生内膜增生:SOS(静脉桥血管支架置入)试验的血管内超声分析。

Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.

机构信息

Veteran Affairs North Texas Healthcare System, Dallas, TX, USA.

出版信息

EuroIntervention. 2011 Dec;7(8):948-54. doi: 10.4244/EIJV7I8A150.

DOI:10.4244/EIJV7I8A150
PMID:22157480
Abstract

AIMS

To compare the intravascular ultrasonography (IVUS) findings between saphenous vein grafts (SVG) treated with paclitaxel-eluting stents (PES) vs. bare metal stents (BMS) in the Stenting Of Saphenous Vein Grafts (SOS) trial.

METHODS AND RESULTS

Of the 80 SOS trial patients, 38 had both baseline and follow-up IVUS examination and were included in this substudy: 17 patients received 28 BMS in 26 lesions and 21 patients received 30 PES in 28 lesions. Quantitative IVUS analysis was performed to determine the volume of in-stent neointimal hyperplasia (NIH) - defined as the difference between stent volume and lumen volume in the stented segments. Baseline characteristics were similar between patients who did and did not undergo baseline and follow-up IVUS. Patients receiving BMS and PES had similar stent and lumen volumes immediately after stenting. At 12-month follow-up, compared to BMS, PES-treated lesions had significantly less NIH volume (3.4 vs. 21.9 mm³, p<0.001) and neointima hyperplasia progression (1.6 vs. 17.1 mm³, p<0.001). No significant differences were seen in the 5 mm segment proximal and distal to the stent.

CONCLUSIONS

Compared to BMS, use of PES in SVG lesions is associated with significantly lower NIH formation, which may help explain the improved clinical outcomes with PES in these lesions.

摘要

目的

比较紫杉醇洗脱支架(PES)与金属裸支架(BMS)治疗的大隐静脉移植物(SVG)的血管内超声(IVUS)结果。

方法和结果

在 Stenting Of Saphenous Vein Grafts(SOS)试验中,80 例 SOS 试验患者中有 38 例同时进行了基线和随访 IVUS 检查,并纳入本亚研究:17 例患者在 26 个病变中接受了 28 个 BMS,21 例患者在 28 个病变中接受了 30 个 PES。定量 IVUS 分析用于确定支架内新生内膜增生(NIH)的体积 - 定义为支架段中支架体积与管腔体积之间的差异。基线特征在接受基线和随访 IVUS 的患者之间相似。接受 BMS 和 PES 的患者在支架置入后即刻具有相似的支架和管腔体积。在 12 个月的随访中,与 BMS 相比,PES 治疗的病变的 NIH 体积明显更小(3.4 与 21.9mm³,p<0.001),新生内膜增生进展更少(1.6 与 17.1mm³,p<0.001)。支架近端和远端 5mm 节段无显著差异。

结论

与 BMS 相比,PES 用于 SVG 病变与 NIH 形成显著降低相关,这可能有助于解释 PES 在这些病变中的临床结局改善。

相似文献

1
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.紫杉醇洗脱支架与裸金属支架相比可减少静脉桥血管的新生内膜增生:SOS(静脉桥血管支架置入)试验的血管内超声分析。
EuroIntervention. 2011 Dec;7(8):948-54. doi: 10.4244/EIJV7I8A150.
2
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.在 SOS(静脉桥血管支架置入术)试验的长期随访中,紫杉醇洗脱支架与裸金属支架置入相比,在静脉桥病变中持续获益。
JACC Cardiovasc Interv. 2011 Feb;4(2):176-82. doi: 10.1016/j.jcin.2010.10.003.
3
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.一项关于紫杉醇洗脱支架与类似裸金属支架用于隐静脉移植血管病变的随机对照试验——SOS(隐静脉移植血管支架置入)试验。
J Am Coll Cardiol. 2009 Mar 17;53(11):919-28. doi: 10.1016/j.jacc.2008.11.029.
4
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.支架置入术后大隐静脉移植物失败的临床表现及血管造影特征:来自SOS(大隐静脉移植物支架置入)试验的见解
JACC Cardiovasc Interv. 2009 Sep;2(9):855-60. doi: 10.1016/j.jcin.2009.06.014.
5
Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).西罗莫司洗脱支架与裸金属支架植入病变大隐静脉桥血管的血管内超声比较(来自RRISC[使用Cypher西罗莫司洗脱支架减少大隐静脉桥血管再狭窄]试验)
Am J Cardiol. 2007 Jul 1;100(1):52-8. doi: 10.1016/j.amjcard.2007.02.052. Epub 2007 May 11.
6
Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: insights from the SOS (Stenting of Saphenous Vein Grafts) trial.紫杉醇洗脱支架与裸金属支架治疗大隐静脉桥病变的心血管事件复发情况:来自SOS(大隐静脉桥支架置入)试验的见解
J Invasive Cardiol. 2011 Jun;23(6):216-9.
7
Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.紫杉醇洗脱支架与裸金属支架植入治疗隐静脉桥病变:SOS(隐静脉桥支架置入)试验的长期随访
Int J Cardiol. 2015;186:261-3. doi: 10.1016/j.ijcard.2015.03.267. Epub 2015 Mar 20.
8
Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.急性心肌梗死中紫杉醇洗脱支架和裸金属支架的血管内超声容积分析:急性心肌梗死血管内超声亚研究中血管重建与支架的协调结果
Circulation. 2009 Nov 10;120(19):1875-82. doi: 10.1161/CIRCULATIONAHA.109.873893. Epub 2009 Oct 26.
9
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.在来自HORIZONS-AMI、TAXUS IV和V以及ATLAS主力、长病变和直接支架研究的汇总血管内超声分析中,ST段抬高型心肌梗死的支架置入与较少的新生内膜增生相关。
Coron Artery Dis. 2014 Nov;25(7):575-81. doi: 10.1097/MCA.0000000000000131.
10
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.紫杉醇洗脱支架置入术后最小支架面积对 9 个月随访通畅率的影响:来自 TAXUS IV、V、VI 及 TAXUS ATLAS Workhorse、长病变、直接支架试验的血管内超声综合分析。
JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.

引用本文的文献

1
Disruptive technological advances in vascular access for dialysis: an overview.血管通路技术在透析中的突破性进展:概述。
Pediatr Nephrol. 2018 Dec;33(12):2221-2226. doi: 10.1007/s00467-017-3853-7. Epub 2017 Nov 29.